MALAT1 and neoplasm: MALAT1 can be used as a candidate blood-based biomarker for the diagnosis of NSCLC, while MALAT1 in paraffin-embedded tissues can indicate a poor prognosis in NSCLC and induces migration and tumour growth [37,39,53].